Alaunos Therapeutics | ZIOP - Ebitda


Alaunos Therapeutics reported $-21.02M in EBITDA for its fiscal quarter ending in March of 2021.





Ebitda Change Date
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
Amgen USD 5.14B 775M Dec/2025
AstraZeneca USD 5.23B 272M Sep/2025
Baxter International USD 426M 36M Sep/2025
Biogen USD 573.2M 253.7M Dec/2025
Bioline Rx USD -554K 2.93M Sep/2025
Bristol-Myers Squibb USD 4.24B 967M Sep/2025
Celltrion KRW 374.56B 352.67B Sep/2025
Corcept Therapeutics USD 10.7M 16.45M Sep/2025
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Curis USD -12.3M 231K Sep/2023
Deva Holding AS TRY 882.9M 201.7M Sep/2023
Dianthus Therapeutics USD -40.19M 5.36M Sep/2025
Divis Laboratories Ltd INR 8.9B 20M Dec/2025
Gilead Sciences USD 4.03B 628M Sep/2025
GlaxoSmithKline GBP 3.36B 179M Sep/2025
Incyte USD 414.5M 92.42M Dec/2025
Intrexon USD -24.7M 2.92M Jun/2024
Ionis Pharmaceuticals USD -157.12M 307.36M Sep/2025
J&J USD 9.52B 389M Sep/2025
Kangmei Pharma CNY 17.3M 20.56M Jun/2025
Karyopharm Therapeutics USD -26.2M 1.83M Sep/2024
Knight Therapeutics CAD 15.51M 3.39M Jun/2025
Laboratorios Farma EUR 34.94M 102.95M Jun/2025
Malin Corporation EUR -1.1M 200K Dec/2024
Medical Developments International AUD 1.78M 3.78M Dec/2024
Merck USD 8.39B 1.97B Sep/2025
Neuren Pharmaceuticals AUD 176.7M 166.79M Dec/2024
Novartis USD 5.88B 290M Sep/2025
Organigram Holdings CAD 6.15M 455K Sep/2025
Pfizer USD 6.08B 351M Sep/2025
Pharma Mar EUR -1.98M 28.13M Sep/2025
PTC Therapeutics USD 20.63M 53.74M Sep/2025
Qiagen NV USD 249.69M 56.53M Dec/2025
Regeneron Pharmaceuticals USD 1.92B 261.9M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sartorius EUR 277.4M 30.5M Dec/2025
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
TG Therapeutics USD 37.7M 25.41M Jun/2025
Tilray USD 8.36M 1.82M Sep/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 531.61M 658.23M Jun/2025